Area of Science: Biosciences

Answer scientific questions across a broad range
of bioscience areas from biotherapeutics to
translational research.

Share

Translational Research

Translational research has shattered the traditional drug development paradigm. The once-serialized processes of target identification, target validation, and lead optimization are now conducted in parallel and in conjunction with a deep understanding of the patient disease state and/or response to therapy.  Additionally, technological developments in deep sequencing, gene expression and proteomics now make it possible to characterize large numbers of client samples.

While this fundamental shift in the drug development paradigm brings hope of shortening development life cycles and improving clinical success rates, it also creates new pain points for researchers who need to work across traditional department barriers in order to access, integrate, and analyze experimental data alongside data from clinical trials.

Accelrys’ award-winning scientific informatics platform, Pipeline Pilot, helps organizations overcome these challenges. Pipeline Pilot unites advanced data mining and analysis tools on a platform that facilitates:

  • Business-rule creation
  • Third-party algorithm and application integration
  • Drag-and-drop workflow building and sharing
  • Interactive reporting

Accessing and integrating clinical and molecular data is simplified with seamless integration to the BioFortis™ LabMatrix system, an HL7-compliant framework that helps users quickly navigate clinical and molecular data.  With Pipeline Pilot, researchers across an organization can successfully conduct and share their translational research.

Additionally, we offer an electronic laboratory notebook, Accelrys Electronic Lab Notebook for Biology, which helps improve operational efficiencies and lower costs by enabling you to plan, execute, and record in vivo and in vitro experiments using a single notebook enterprise-wide.

Browse By:

How does your company measure up? take the free maturity model assessment and start realizing faster,repeatable results from r and d investments.